logo
Best fountains for cats who love fresh water

Best fountains for cats who love fresh water

Chicago Tribune18-07-2025
Your pets need proper hydration throughout the day, especially during the hotter months when you might not be home that often. Most owners put out a bowl of water, but you can't predict how thirsty your pet will get.
An excellent solution is to get a cat fountain for your feline friend. With a steady supply of fresh, cold water, you can leave the house stress-free knowing that nourishing fluids are always available. The Catit Fresh & Clear Stainless Steel Cat Water Fountain is an excellent choice, as it has a large capacity and is partially made from metal.
Close to a wall socket
Any pet fountain must be placed close to a wall socket. The small internal water pump needs electricity to push the water through the system, or it won't work. However, there are fountains that have a USB connection. These can plug into a wall socket through an adapter but can also operate off a power bank in an emergency or power cut.
Limited capacity
A cat fountain doesn't connect to your main water line and has a limited capacity for water storage. When the levels get low, you must top up the tank. Depending on how many cats you have and the average summer temperatures where you live, you might find yourself adding water more regularly. If tank capacity is a concern, it's best to get two cat fountains and place them in different spots in the house.
Metal is better than plastic
Aim for a cat fountain made of metal instead of plastic. Not only does a shiny metal fountain look better, but it keeps the water fresher. Plastic can, over time, alter the water's taste. Also, some cats can develop feline chin acne when eating or drinking from plastic bowls. It is essentially a cat allergy to plastic and should be avoided.
Filtration system
Stagnant or dirty water is dangerous to pets, especially cats with a delicate immune system. A good-quality cat fountain has a multistep filtration system that clears the water of dust particles, debris or harmful elements. It's not as complex as household filtration systems, and much easier to maintain.
In most cases, you pop out the filter and replace it with a new one, but there is a catch. It's rare to find interchangeable filters between different brands. Usually, you can only use the same filters as the fountain maker.
Large water tank
With limited capacity, you should opt for a fountain with a large water tank. The tank's size determines the fountain's overall height, but it shouldn't be a problem for any cat to reach. A larger capacity means that more water is available during the day, and you wouldn't need to top it up more than once or twice a week.
Easy to clean
Another crucial element of a cat fountain is maintenance. You don't want to drink water from a dirty glass, so your cat shouldn't have to drink from a dirty fountain. The water filters are simple to replace, but the fountain requires a thorough cleaning regularly. A good-quality cat fountain makes this easy by being made of only a few components, able to come apart and easy to wash.
A cat fountain isn't as expensive as you might think. A basic fountain with a replaceable filter costs $20-$30, while a metal fountain with a large water tank runs $40-$50. The filters are usually sold in packs of three or five, and go for $10-$25.
Do you use tap water or bottled water for a fountain?
A. Tap water is perfectly fine for a cat fountain, as long as the water is also fit for human consumption. There's no need to use bottled water — the filtration system will take care of any impurities.
How do you clean a cat fountain?
A. While water circulation prevents bacteria from growing, you can never be too cautious. Simply take the fountain apart and rinse it under hot water. Some fountain components are suitable for a dishwasher, too.
Top cat fountain
Catit Fresh & Clear Stainless Steel Cat Water Fountain
What you need to know: This cat fountain has a plastic base and tank, but there's a metal water bowl on the top.
What you'll love: The recirculating system cools and aerates the water while the internal carbon filter cleans the water of any debris. The tank has a capacity of around 64 fluid ounces.
What you should consider: The fountain comes with a 5-foot cable.
Top cat fountain for the money
PETKIT Cat Eversweet Solo SE Water Fountain with Wireless Pump
What you need to know: This half-gallon cat fountain is perfect for small to medium pets, as you can monitor their liquid intake through the transparent sides.
What you'll love: The fountain has an indicator light to let you know when it's out of water. It's made of plastic and includes a carbon filter, and the wireless pump is quiet.
What you should consider: It uses a USB cable, so you'll need an adapter for a wall socket.
Worth checking out
Petdiary Automatic Cat Water Fountain
What you need to know: This 101-ounce fountain is made of food-grade melamine and has five filtration layers.
What you'll love: The transparent sides let you keep an eye on the water level, but it has built-in dry run protection. There is also a light that turns on when the surroundings get dark.
What you should consider: It has a wall socket connection, so it isn't compatible with power banks.
BestReviews spends thousands of hours researching, analyzing and testing products to recommend the best picks for most consumers. BestReviews and its newspaper partners may earn a commission if you purchase a product through one of our links.
Distributed by Tribune Content Agency, LLC.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CLEAR Joins White House and CMS Effort to Power an Interoperable, Secure Digital Health Ecosystem
CLEAR Joins White House and CMS Effort to Power an Interoperable, Secure Digital Health Ecosystem

Business Upturn

time2 days ago

  • Business Upturn

CLEAR Joins White House and CMS Effort to Power an Interoperable, Secure Digital Health Ecosystem

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — CLEAR (NYSE: YOU), the secure identity platform, is participating in the Centers for Medicare & Medicaid Services (CMS) Health Tech Ecosystem initiative, a nationwide effort to deliver a more connected, patient-centered healthcare system. CLEAR was proud to stand alongside government, healthcare, and technology leaders at the White House this week to support the launch of this national collaboration, and to reinforce its role as the trusted, full service Identity Assurance Level 2 (IAL2)/Authenticator Assurance Level 2 (AAL2) identity layer underpinning partner ecosystems across healthcare. 'CLEAR applauds the Administration's commitment to accelerating the digital transformation of healthcare and is proud to be a trusted partner in this nationwide effort,' said Caryn Seidman Becker, CEO of CLEAR. 'By serving as an IAL2 identity layer in healthcare ecosystems, CLEAR is helping to kill the clipboard, eliminate friction, and give patients control of their medical information in a secure, seamless way. We believe identity is the key to unlocking personalized, efficient, and patient-centered care.' At the heart of this CMS-led effort is a push to make health data more accessible, interoperable, and actionable, empowering patients, reducing provider burden, and improving outcomes. CLEAR's reusable identity platform for healthcare organizations and businesses, CLEAR1, is already enabling this transformation across leading platforms and health systems, including Epic, Surescripts, Wellstar, Community Health Network, University of Miami Health and These partners are leveraging CLEAR1 for use cases such as streamlining patient onboarding and check-in, enhancing workforce security, simplifying access to medical records, and strengthening data protection. Together, these efforts demonstrate how secure, interoperable identity can reduce friction, lower costs, and enable a more connected healthcare experience. CLEAR1 is a NIST IAL2/AAL2-compliant identity solution that gives patients and providers a reusable, privacy-centric credential to unlock services across the care journey, whether creating a MyChart account, verifying coverage, or accessing claims data. Over 60 companies have signed on to the CMS Health Tech Ecosystem pledge, committing to advance tools that: Help patients manage chronic conditions like diabetes and obesity Use AI assistants to navigate symptoms and schedule care 'Kill the clipboard' by digitizing check-in and intake Securely share data across trusted networks using modern identity credentials 'We are excited that identity services – like CLEAR – are making it possible for patients and providers to use verified, secure identity as part of CMS's Health Tech Ecosystem,' said Amy Gleason, Acting Administrator for the U.S. DOGE Service and Strategic Advisor to the Department of Health and Human Services and the Centers for Medicare and Medicaid. 'Checking in at the doctor's office should be the same as boarding a flight. Patients should be able to scan a QR code to instantly and safely share their identity, insurance and medical history'. 'Our work with CLEAR has meaningfully improved the speed and reliability of provider identity verification across our network,' said Frank Harvey, CEO of Surescripts. 'It's a powerful example of how focused collaboration can drive real progress. This pledge builds on that momentum—demonstrating how innovators across healthcare are advancing interoperability to reduce administrative burden and refocus clinicians' time where it matters most: patient care.' 'Identity is foundational to creating the connected, consumer-first healthcare experience that people expect, and it's what was built to deliver,' said Kristen Valdes, CEO and Founder of 'Our partnership with CLEAR brings a trusted, IAL2-compliant identity layer into that experience, giving patients and caregivers a seamless, unified way to access and share their health information across providers and platforms.' 'As part of our pledge to become a CMS Aligned Network, our relationship and planned integration with CLEAR will give us a unique opportunity to bring IAL2 identity verification to providers who are newer to the interoperability space,' said Therasa Bell, President and Founder of Kno2. 'That includes nurses, physical therapists, behavioral health providers, dentists, and paramedics, and it will enable them to securely communicate and share patient records across the broader healthcare ecosystem.' 'Modern identity is the key to enabling safe, secure, and trusted data exchange across healthcare,' said Aneesh Chopra, former Chief Technology Officer of the United States. 'CLEAR's work to deliver IAL2-compliant digital identity helps unlock the promise of interoperability—giving patients and providers the confidence to share information seamlessly and securely.' CLEAR1 is already powering many of these functions across CLEAR's health, financial services, and workforce partners—and stands ready to support the rollout of CMS-Aligned Networks in 2026 and beyond. About CLEAR CLEAR's mission is to strengthen security and create frictionless experiences. With over 31 million Members and a growing network of partners across the world, CLEAR's secure identity platform is transforming the way people live, work, and travel. Whether you are traveling, at the stadium, or on your phone, CLEAR connects you to the things that make you, you – making everyday experiences easier, more secure, and friction-free. CLEAR is committed to privacy done right. Members are always in control of their own information, and we never sell Member data. For more information, visit . Forward-Looking Statements This release may contain statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. This includes, without limitation, statements relating to CLEAR's participation in the CMS Health Tech Ecosystem initiative. Investors are cautioned that any and such forward-looking statements are not guarantees of future performance or results and involve risks and uncertainties, and that actual results, developments and events may differ materially from those in the forward-looking statements as a result of various factors, including risks associated with the initiative and CLEAR's participation therein, and those described in the Company's filings within the Securities and Exchange Commission, including the sections titled 'Risk Factors' in our Annual Report on Form 10- K. The Company disclaims any obligation to update any forward-looking statements contained herein. CLEAR [email protected] This press release was published by a CLEAR® Verified individual. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash

CLEAR Joins White House and CMS Effort to Power an Interoperable, Secure Digital Health Ecosystem
CLEAR Joins White House and CMS Effort to Power an Interoperable, Secure Digital Health Ecosystem

Yahoo

time2 days ago

  • Yahoo

CLEAR Joins White House and CMS Effort to Power an Interoperable, Secure Digital Health Ecosystem

As the IAL2 identity layer for major healthcare partners, CLEAR supports CMS's nationwide initiative to modernize care through trusted, interoperable technologies NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- CLEAR (NYSE: YOU), the secure identity platform, is participating in the Centers for Medicare & Medicaid Services (CMS) Health Tech Ecosystem initiative, a nationwide effort to deliver a more connected, patient-centered healthcare system. CLEAR was proud to stand alongside government, healthcare, and technology leaders at the White House this week to support the launch of this national collaboration, and to reinforce its role as the trusted, full service Identity Assurance Level 2 (IAL2)/Authenticator Assurance Level 2 (AAL2) identity layer underpinning partner ecosystems across healthcare. 'CLEAR applauds the Administration's commitment to accelerating the digital transformation of healthcare and is proud to be a trusted partner in this nationwide effort,' said Caryn Seidman Becker, CEO of CLEAR. 'By serving as an IAL2 identity layer in healthcare ecosystems, CLEAR is helping to kill the clipboard, eliminate friction, and give patients control of their medical information in a secure, seamless way. We believe identity is the key to unlocking personalized, efficient, and patient-centered care.' At the heart of this CMS-led effort is a push to make health data more accessible, interoperable, and actionable, empowering patients, reducing provider burden, and improving outcomes. CLEAR's reusable identity platform for healthcare organizations and businesses, CLEAR1, is already enabling this transformation across leading platforms and health systems, including Epic, Surescripts, Wellstar, Community Health Network, University of Miami Health and These partners are leveraging CLEAR1 for use cases such as streamlining patient onboarding and check-in, enhancing workforce security, simplifying access to medical records, and strengthening data protection. Together, these efforts demonstrate how secure, interoperable identity can reduce friction, lower costs, and enable a more connected healthcare experience. CLEAR1 is a NIST IAL2/AAL2-compliant identity solution that gives patients and providers a reusable, privacy-centric credential to unlock services across the care journey, whether creating a MyChart account, verifying coverage, or accessing claims data. Over 60 companies have signed on to the CMS Health Tech Ecosystem pledge, committing to advance tools that: Help patients manage chronic conditions like diabetes and obesity Use AI assistants to navigate symptoms and schedule care 'Kill the clipboard' by digitizing check-in and intake Securely share data across trusted networks using modern identity credentials "We are excited that identity services - like CLEAR - are making it possible for patients and providers to use verified, secure identity as part of CMS's Health Tech Ecosystem," said Amy Gleason, Acting Administrator for the U.S. DOGE Service and Strategic Advisor to the Department of Health and Human Services and the Centers for Medicare and Medicaid. "Checking in at the doctor's office should be the same as boarding a flight. Patients should be able to scan a QR code to instantly and safely share their identity, insurance and medical history". 'Our work with CLEAR has meaningfully improved the speed and reliability of provider identity verification across our network,' said Frank Harvey, CEO of Surescripts. 'It's a powerful example of how focused collaboration can drive real progress. This pledge builds on that momentum—demonstrating how innovators across healthcare are advancing interoperability to reduce administrative burden and refocus clinicians' time where it matters most: patient care.' 'Identity is foundational to creating the connected, consumer-first healthcare experience that people expect, and it's what was built to deliver,' said Kristen Valdes, CEO and Founder of 'Our partnership with CLEAR brings a trusted, IAL2-compliant identity layer into that experience, giving patients and caregivers a seamless, unified way to access and share their health information across providers and platforms.' 'As part of our pledge to become a CMS Aligned Network, our relationship and planned integration with CLEAR will give us a unique opportunity to bring IAL2 identity verification to providers who are newer to the interoperability space,' said Therasa Bell, President and Founder of Kno2. 'That includes nurses, physical therapists, behavioral health providers, dentists, and paramedics, and it will enable them to securely communicate and share patient records across the broader healthcare ecosystem." 'Modern identity is the key to enabling safe, secure, and trusted data exchange across healthcare,' said Aneesh Chopra, former Chief Technology Officer of the United States. 'CLEAR's work to deliver IAL2-compliant digital identity helps unlock the promise of interoperability—giving patients and providers the confidence to share information seamlessly and securely.' CLEAR1 is already powering many of these functions across CLEAR's health, financial services, and workforce partners—and stands ready to support the rollout of CMS-Aligned Networks in 2026 and beyond. About CLEARCLEAR's mission is to strengthen security and create frictionless experiences. With over 31 million Members and a growing network of partners across the world, CLEAR's secure identity platform is transforming the way people live, work, and travel. Whether you are traveling, at the stadium, or on your phone, CLEAR connects you to the things that make you, you – making everyday experiences easier, more secure, and friction-free. CLEAR is committed to privacy done right. Members are always in control of their own information, and we never sell Member data. For more information, visit Forward-Looking StatementsThis release may contain statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. This includes, without limitation, statements relating to CLEAR's participation in the CMS Health Tech Ecosystem initiative. Investors are cautioned that any and such forward-looking statements are not guarantees of future performance or results and involve risks and uncertainties, and that actual results, developments and events may differ materially from those in the forward-looking statements as a result of various factors, including risks associated with the initiative and CLEAR's participation therein, and those described in the Company's filings within the Securities and Exchange Commission, including the sections titled "Risk Factors" in our Annual Report on Form 10- K. The Company disclaims any obligation to update any forward-looking statements contained herein. CLEARmedia@ This press release was published by a CLEAR® Verified in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Exonate plans ‘CLEAR-DE' Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disease
Exonate plans ‘CLEAR-DE' Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disease

Business Wire

time4 days ago

  • Business Wire

Exonate plans ‘CLEAR-DE' Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disease

CAMBRIDGE, England--(BUSINESS WIRE)--Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical trial for its lead candidate EXN407. The CLEAR-DE (Clinical Evaluation of a New Eye Drop for Alleviating Retinopathy in Diabetic Eye Disease) trial will further evaluate the clinical efficacy, optimal dosing and safety profile of EXN407 in patients with non-proliferative diabetic retinopathy (NPDR). The progression to a Phase IIb clinical study follows encouraging results from Exonate's Phase Ib/IIa study in March 2024. In the study, lead candidate EXN407 met its primary safety and tolerability endpoints, with no drug-related serious adverse events, and high patient compliance. Importantly, exploratory efficacy signals showed a reduction in vascular leakage, a key pathological driver in diabetic retinopathy. The Phase IIb trial to investigate the efficacy of EXN407 in NPDR patients is planned to begin in early 2026, with 140 patients currently enrolled across multiple sites in Australia, the Middle East and China. Diabetic retinopathy (DR) is a leading cause of vision loss globally. An estimated one-third of the nearly 500 million people living with diabetes are affected by NPDR, the early stage of diabetic eye disease, which can lead to more severe, vision-threatening complications. Current therapeutic approaches involve monthly intraocular injections, initiated only after symptoms appear. This limits opportunities for early therapeutic benefit, and due to the invasive nature and frequency, is often deferred until irreversible damage has occurred. EXN407 is a first-in-class, twice-daily topical formulation of a selective SRPK1 inhibitor – a minimally-invasive approach with potential to become the first effective eye-drop therapy for NPDR and diabetic macular oedema (DME). Designed to modulate expression of vascular endothelial growth factor (VEGF) via alternative mRNA splicing, EXN407 selectively inhibits the pro-angiogenic isoforms that drive disease progression, causing abnormal and leaky blood vessel formation in the retina. ' The Phase Ib/IIa data demonstrated the clear potential of EXN407 as a non-invasive treatment for diabetic eye disease, ' said Dr. Catherine Beech, Chief Executive Officer of Exonate. ' This therapy could transform the treatment landscape for early-stage disease by providing clinical benefit while avoiding the burden of injections, representing a significant advancement for patients and physicians alike. We're excited to progress to the CLEAR-DE Phase IIb trial and are actively seeking strategic partners to support its execution.' For more information about Exonate's pipeline and clinical development plans, please visit:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store